MARRELLI, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 27.137
EU - Europa 22.325
AS - Asia 10.545
SA - Sud America 1.945
AF - Africa 321
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 18
Totale 62.330
Nazione #
US - Stati Uniti d'America 26.835
GB - Regno Unito 5.168
RU - Federazione Russa 4.867
CN - Cina 4.211
SG - Singapore 3.276
IE - Irlanda 3.120
IT - Italia 2.175
UA - Ucraina 1.754
BR - Brasile 1.680
SE - Svezia 1.545
DE - Germania 1.231
FR - Francia 1.062
HK - Hong Kong 942
FI - Finlandia 639
KR - Corea 596
VN - Vietnam 568
IN - India 237
ES - Italia 178
CA - Canada 154
AR - Argentina 114
BE - Belgio 100
BD - Bangladesh 92
TR - Turchia 91
MX - Messico 87
NL - Olanda 83
PL - Polonia 82
CI - Costa d'Avorio 74
IQ - Iraq 68
JP - Giappone 67
ZA - Sudafrica 66
IR - Iran 53
AT - Austria 49
ID - Indonesia 44
LT - Lituania 42
RO - Romania 40
EG - Egitto 38
SA - Arabia Saudita 36
CZ - Repubblica Ceca 31
EC - Ecuador 31
AU - Australia 30
PK - Pakistan 29
MU - Mauritius 27
PT - Portogallo 27
PY - Paraguay 27
JO - Giordania 26
MA - Marocco 26
UZ - Uzbekistan 24
AE - Emirati Arabi Uniti 23
VE - Venezuela 23
KE - Kenya 22
CL - Cile 20
PH - Filippine 20
KG - Kirghizistan 19
AZ - Azerbaigian 17
CH - Svizzera 17
EU - Europa 16
CO - Colombia 15
ET - Etiopia 14
GR - Grecia 14
KZ - Kazakistan 14
PE - Perù 14
TN - Tunisia 14
UY - Uruguay 14
DZ - Algeria 13
IL - Israele 13
MY - Malesia 12
BG - Bulgaria 11
SI - Slovenia 10
SN - Senegal 10
TW - Taiwan 10
EE - Estonia 9
PA - Panama 9
CR - Costa Rica 8
JM - Giamaica 8
LU - Lussemburgo 8
LV - Lettonia 8
NZ - Nuova Zelanda 8
DO - Repubblica Dominicana 7
MD - Moldavia 7
NP - Nepal 7
TT - Trinidad e Tobago 7
AL - Albania 6
BO - Bolivia 6
BY - Bielorussia 6
DK - Danimarca 6
NG - Nigeria 6
RS - Serbia 6
AM - Armenia 5
CY - Cipro 5
HN - Honduras 5
NO - Norvegia 5
TH - Thailandia 5
AO - Angola 4
GE - Georgia 4
HU - Ungheria 4
LA - Repubblica Popolare Democratica del Laos 4
LB - Libano 4
MM - Myanmar 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
Totale 62.276
Città #
Southend 4.666
Dallas 4.096
Fairfield 3.121
Dublin 3.090
Ashburn 1.873
Singapore 1.791
Chandler 1.612
Jacksonville 1.516
Moscow 1.370
Woodbridge 1.370
Santa Clara 1.282
Wilmington 1.175
Seattle 1.130
Houston 1.101
Beijing 1.027
Cambridge 990
Hong Kong 935
Ann Arbor 780
Seoul 578
Princeton 575
Hefei 541
Nanjing 477
Siena 385
Munich 354
New York 324
Los Angeles 321
The Dalles 277
Helsinki 243
Boardman 232
San Mateo 227
Council Bluffs 186
Shanghai 186
São Paulo 167
Ho Chi Minh City 164
San Diego 164
Florence 151
Milan 150
Buffalo 148
Shenyang 146
Nanchang 141
Columbus 130
Málaga 125
Hanoi 116
Redondo Beach 101
Tianjin 96
Brussels 94
London 94
Dong Ket 89
Hebei 89
Rome 86
Changsha 81
Turku 81
Düsseldorf 78
Abidjan 74
San Jose 72
San Francisco 70
Kunming 68
Jiaxing 66
Frankfurt am Main 62
Jinan 62
Warsaw 62
Bengaluru 57
Tokyo 56
Guangzhou 53
Rio de Janeiro 52
Phoenix 51
Dearborn 50
Brooklyn 48
Chicago 48
Menlo Park 48
Toronto 48
Ningbo 46
Norwalk 46
Venezia 46
Johannesburg 44
Montreal 44
Boston 43
Stockholm 43
Zhengzhou 43
Denver 42
Atlanta 39
Chennai 38
Belo Horizonte 37
Brasília 37
Lappeenranta 37
Orem 34
Manchester 33
Poplar 33
Washington 33
Falls Church 32
Naples 32
Vienna 32
Hangzhou 30
Mexico City 29
Nuremberg 29
Höst 28
Curitiba 27
Port Louis 27
Portsmouth 27
Amman 25
Totale 42.405
Nome #
Patologie del duodeno 556
612. Molecular background of high risk and low risk areas of gastric cancer in Italy 446
354. KRAS mutation in gastric cancer- molecular, and clinico-pathological characteristic 347
Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) 329
Gastric cancer maximum tumour diameter reduction rate at CT examination as a radiological index for predicting histopathological regression after neoadjuvant treatment: A multicentre GIRCG study 328
65. Molecular surgery for gastric cancer-role of microsatellite instability in elderly patients 320
530. Minimally invasive surgery for the treatment of colo-rectal adenocarcinoma: Laparoscopic and robotic approach 315
338. Comparing characteristics and survival outcomes of adolescent and young adults to mature patients with colorectal cancer 312
613. Lymph node metastases in microsatellite unstable gastric cancer 308
C-Met targeting in advanced gastric cancer: An open challenge 306
611. Gastric cancer patients with familial aggregation of gastric cancer and Lynch syndrome associated cancers with microsatellite instability 295
353. PIK3CA mutation in gastric cancer and the role of different codon mutations in the new molecular division of that neoplasm 294
A clinical case of duodenal gastrointestinal stromal tumor with a peculiarity in the surgical approach. 289
A case of pancreatic somatostatinoma [Considerazioni su un caso di somatostatinoma a localizzazione pancreatica] 285
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer 283
610. Heterogeneity of new molecular gastric cancer classifications. Clinico-pathological characteristic 278
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer 277
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis 272
Breast cancer local recurrence: risk factors and prognostic relevance of early time to recurrence 271
Clinical evaluation of the Mannheim Prognostic Index in post-operative peritonitis: a prospective cohort study 265
A case of small-cell gastric carcinoma with an adenocarcinoma component and hepatic metastases: treatment with systemic and intra-hepatic chemotherapy 264
Accuracy of MDCT in the Preoperative Definition of Peritoneal Cancer Index (PCI) in Patients with Advanced Ovarian Cancer Who Underwent Peritonectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) 262
Age Related Co-Morbidities in Colorectal Cancer Patients: Surgical Problems and Prognostic Impact 262
Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases 258
Molecular key to understand the gastric cancer biology in elderly patients—The role of microsatellite instability 258
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 257
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer 256
Familial aggregation of gastric cancer with microsatellite instability** 254
Comparison between 7th and 8th edition of AJCC TNM staging system for gastric cancer: Old problems and new perspectives 254
CA 19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions 254
Recurrence after surgery in esophago-gastric junction adenocarcinoma: Current management and future perspectives 251
Robotic versus laparoscopic gastrectomy for gastric cancer: protocol for umbrella review of systematic reviews and meta-analyses 250
A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. 249
E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. 248
A rare case of primary small bowel adenocarcinoma with intussusception. 246
Clinical impact of molecular classifications in gastric cancer 244
KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status 244
Hyperthermic intrathoracic chemotherapy after extended pleurectomy and decortication for malignant pleura mesothelioma: An observational study on outcome and microcirculatory changes 244
High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability 243
E-cadherin and hereditary diffuse gastric cancer. 241
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer 241
The pattern of lymph node metastases in microsatellite unstable gastric cancer 238
Re-evaluation of Mannheim prognostic index in perforative peritonitis: Prognostic role of advanced age. A prospective cohort study 238
Is tissue inhibitor of metalloproteinase-1 a new prognosticator for breast cancer? An analysis of 266 cases 237
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 236
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer 236
Complications after surgery for gastric cancer in patients aged 80 years and over 236
A new way to experience the International Gastric Cancer Association Congress: the Web Round Tables 235
Is sleeve gastrectomy a therapeutic procedure for all obese patients? 234
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 234
K-RAS mutation in gastric cancer and its link with microsatellite instability status 233
A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer 233
Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer 232
Signet ring cell percentage in poorly cohesive gastric cancer patients: a potential novel predictor of survival 232
CDH1 C-160A promoter polymorphism and gastric cancer risk 231
Evidence of tumor microsatellite instability in gastric cancer with familial aggregation 231
Accuracy of MDCT in preoperative definition of maximum tumour diameter in patients with gastric cancer 229
Computed Tomographic Evaluation of Mesentery : Diagnostic Value in Acute Mesenteric Ischemia. 227
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study 227
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results 226
A comprehensive PDX gastric cancer collection captures cancer cell–intrinsic transcriptional MSI traits 225
Antimicrobial prophylaxis reduces the rate of surgical site infection in upper gastrointestinal surgery: a systematic review 225
Clinical and oncological value of preoperative BMI in gastric cancer patients: A single center experience 222
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study 222
Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer 222
Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer 222
Accuracy of MDCT in preoperative definition of maximum tumor diameter in patients with gastric cancer 222
Accuracy of MDCT in preoperative definition of maximum tumor diameter in patients with gastric cancer 221
Presacral ganglioneuroma: a case report and review of literature 220
Potential impact of molecular classification on tailored lymphadenectomy for gastric cancer 220
Carcinomi squamosi e adenosquamosi del colon-retto: descrizione di tre casi clinici e revisione della letteratura 216
Robotic single docking total colectomy for ulcerative colitis: First experience with a novel technique 215
Il ruolo della chemioipertermia nel carcinoma del colon-retto 214
Factors influencing survival after hepatectomy for metastases from gastric cancer 213
Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer 213
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data 213
Super-extended (D3) lymphadenectomy in advanced gastric cancer. 212
High incidence of familial gastric cancer in Tuscany, a region in Italy. 211
Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an italian family 211
The percentage of signet ring cells is inversely related to aggressive behavior and poor prognosis in mixed-type gastric cancer 210
Approccio multimodale al trattamento delle metastasi epatiche. 209
Naso-gastric or naso-jejunal decompression after partial distal gastrectomy for gastric cancer. Final results of a multicenter prospective randomized trial 209
PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene 209
Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study 208
Elastofibroma dorsi: three cases of personal experience 206
Primary non-Hodgkin's breast lymphoma: surgical approach. 203
From digital world to real life: A robotic approach to the esophagogastric junction with a 3D printed model 202
Different pathological features and prognosis in gastric cancer patients coming from high-risk and low-risk areas of Italy. 202
Gastric Cancer and Synchronous Hepatic Metastases: Is It Possible to Recognize Candidates to R0 Resection? 201
Treatment of the intraabdominal abscesses through percutaneous ultrasound-guided drainage in oncological patients: Clinical and microbiological data. 201
Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study 201
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience 200
Targeting VEGFR-2 in Metastatic Gastric Cancer: Results From a Literature-Based Meta-Analysis 199
Ultraviolet radiation resistance-associated polyadenine deletions in human gastric cancer 198
Cell kinetic patterns in early gastric cancer 197
609. Pathology of signet-ring cell in gastric cancer and its prognostic value in surgical treatment 197
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts 197
Trattamento chirurgico radicale di emangiopericitoma retroperitoneale recidivo: case report. 197
Histological variety of gastric carcinoma and Helicobacter pylori cagA and vacA polymorphism 196
High accuracy of multislices computed tomography (MSCT) for para-aortic lymph node metastases from gastric cancer: a prospective single-center study. 195
Totale 24.457
Categoria #
all - tutte 195.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 195.136


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.874 0 0 0 0 0 654 234 903 703 464 487 429
2021/20224.288 375 532 279 293 218 167 208 147 224 463 477 905
2022/20236.032 352 384 815 860 587 1.320 146 465 601 177 171 154
2023/20244.581 222 137 374 164 149 1.215 1.681 82 25 161 59 312
2024/20259.796 315 517 804 484 1.311 676 235 573 839 390 1.143 2.509
2025/202616.355 1.838 3.682 2.937 2.735 4.473 690 0 0 0 0 0 0
Totale 62.913